|
83
|
264
|
2dwbA |
Aurora-a kinase complexed with amppnp |
|
69
|
268
|
2e9vA |
Structure of h-chk1 complexed with a859017 |
|
89
|
278
|
2e2bA |
Crystal structure of the c-abl kinase domain in complex with inno-406 |
|
97
|
324
|
2eb2A |
Crystal structure of mutated egfr kinase domain (g719s) |
|
94
|
323
|
2eb3A |
Crystal structure of mutated egfr kinase domain (l858r) in complex with amppnp |
|
79
|
269
|
2e9oA |
Structure of h-chk1 complexed with aa582939 |
|
74
|
298
|
2ds1A |
Human cyclin dependent kinase 2 complexed with the cdk4 inhibitor |
|
68
|
263
|
2dq7X |
Crystal structure of fyn kinase domain complexed with staurosporine |
|
68
|
298
|
2duvA |
Structure of cdk2 with a 3-hydroxychromones |
|
85
|
300
|
2dylA |
Crystal structure of human mitogen-activated protein kinase kinase 7 activated mutant (s287d, t291d) |
|
102
|
336
|
2cpkE |
Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase |
|
86
|
271
|
2clqA |
Structure of mitogen-activated protein kinase kinase kinase 5 |
|
86
|
297
|
2cchA |
The crystal structure of cdk2 cyclin a in complex with a substrate peptide derived from cdc modified with a gamma-linked atp analogue |
|
86
|
292
|
2cdzA |
Crystal structure of the human p21-activated kinase 4 in complex with cgp74514a |
|
88
|
293
|
2csnA |
Binary complex of casein kinase-1 with cki7 |
|
94
|
296
|
2cmwA |
Structure of human casein kinase 1 gamma-1 in complex with 2-(2- hydroxyethylamino)-6-(3-chloroanilino)-9-isopropylpurine |
|
79
|
292
|
2cn8A |
Crystal structure of human chk2 in complex with debromohymenialdisine |
|
80
|
292
|
2cjmA |
Mechanism of cdk inhibition by active site phosphorylation: cdk2 y15p t160p in complex with cyclin a structure |
|
78
|
266
|
2cguA |
Identification of chemically diverse chk1 inhibitors by receptor- based virtual screening |
|
77
|
267
|
2cgvA |
Identification of chemically diverse chk1 inhibitors by receptor- based virtual screening |
|
81
|
298
|
2c69A |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
76
|
263
|
2c6eA |
Aurora a kinase activated mutant (t287d) in complex with a 5- aminopyrimidinyl quinazoline inhibitor |
|
84
|
269
|
2c3iB |
Crystal structure of human pim1 in complex with imidazopyridazin i |
|
84
|
297
|
2cn5A |
Crystal structure of human chk2 in complex with adp |
|
100
|
298
|
2chlA |
Structure of casein kinase 1 gamma 3 |
|
77
|
298
|
2c6kA |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
80
|
296
|
2c5vA |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
|
79
|
296
|
2c68A |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
82
|
298
|
2clxA |
4-arylazo-3,5-diamino-1h-pyrazole cdk inhibitors: sar study, crystal structure in complex with cdk2, selectivity, and cellular effects |
|
91
|
301
|
2ckeA |
Human death-associated drp-1 kinase in complex with inhibitor |
|
78
|
266
|
2cgwA |
Identification of chemically diverse chk1 inhibitors by receptor- based virtual screening |
|
76
|
296
|
2c6oA |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
86
|
296
|
2c6tA |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
85
|
296
|
2c5oA |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
|
89
|
301
|
2c4gA |
Structure of cdk2-cyclin a with pha-533514 |
|
75
|
268
|
2cgxA |
Identification of chemically diverse chk1 inhibitors by receptor- based virtual screening |
|
77
|
297
|
2cciA |
Crystal structure of phospho-cdk2 cyclin a in complex with a peptide containing both the substrate and recruitment sites of cdc6 |
|
81
|
298
|
2c6iA |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
80
|
297
|
2c5yA |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
|
78
|
296
|
2c5xA |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
|
78
|
272
|
2c3lA |
Identification of a buried pocket for potent and selective inhibition of chk1: prediction and verification |
|
77
|
296
|
2c6mA |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
80
|
296
|
2c5nA |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
|
78
|
264
|
2c6dA |
Aurora a kinase activated mutant (t287d) in complex with adpnp |
|
125
|
447
|
2c0tA |
Src family kinase hck with bound inhibitor a-641359 |
|
78
|
265
|
2c3jA |
Identification of a buried pocket for potent and selective inhibition of chk1: prediction and verification |
|
77
|
298
|
2c6lA |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
127
|
447
|
2c0iA |
Src family kinase hck with bound inhibitor a-420983 |
|
84
|
273
|
2bziB |
Crystal structure of the human pim1 in complex with a ruthenium organometallic ligand ru2 |
|
95
|
295
|
2c47A |
Structure of casein kinase 1 gamma 2 |